celastrol has been researched along with Diabetes Mellitus, Type 2 in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 4 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, M; Zhang, Y | 1 |
| Chen, B; Hassan, M; He, Q; Li, X; Liu, X; Shen, Z; Song, Y; Wang, G; Wu, L; Wu, Q; Xiao, X; Zhang, H; Zhang, L; Zhao, Y; Zhou, D; Zhou, W | 1 |
| Gu, J; Li, HF; Qin, L; Shi, YN; Zhang, CJ; Zhu, N | 1 |
| Feng, Y; He, W; Li, X; Xu, S; Xu, W; Yang, H | 1 |
| Chen, LM; Guan, Y; Han, LP; Li, CJ; Ma, ZJ; Sun, B; Xie, Y | 1 |
| Leibel, R; Tortoriello, DV; Weisberg, S | 1 |
| Choi, JW; Feng, X; Ibi, D; Lee, J; Liu, J; Mucka, P; Ozcan, U; Salazar Hernández, MA | 1 |
2 review(s) available for celastrol and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Celastrol functions as an emerging manager of lipid metabolism: Mechanism and therapeutic potential.
Topics: Animals; Diabetes Mellitus, Type 2; Lipid Metabolism; Lipids; Mice; Pentacyclic Triterpenes; Triterpenes | 2023 |
Celastrol in metabolic diseases: Progress and application prospects.
Topics: Animals; Diabetes Mellitus, Type 2; Energy Metabolism; Humans; Inflammation; Insulin Resistance; Lipid Metabolism; Metabolic Diseases; Obesity; Pentacyclic Triterpenes; Tripterygium | 2021 |
5 other study(ies) available for celastrol and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Combining bioinformatics, network pharmacology and artificial intelligence to predict the mechanism of celastrol in the treatment of type 2 diabetes.
Topics: ADAMTS Proteins; Artificial Intelligence; Computational Biology; Diabetes Mellitus, Type 2; Gene Expression Profiling; Humans; Molecular Docking Simulation; Network Pharmacology; Transforming Growth Factor beta | 2022 |
Celastrol targets the ChREBP-TXNIP axis to ameliorates type 2 diabetes mellitus.
Topics: Animals; Blood Glucose; Carrier Proteins; Diabetes Mellitus, Type 2; Glucose; Hypoglycemic Agents; Mice; Molecular Docking Simulation; Pentacyclic Triterpenes; Thioredoxins | 2023 |
Protective Effects of Celastrol on Diabetic Liver Injury via TLR4/MyD88/NF-κB Signaling Pathway in Type 2 Diabetic Rats.
Topics: Animals; Anti-Inflammatory Agents; Cytoprotection; Diabetes Mellitus, Type 2; Disease Models, Animal; Interleukin-1beta; Liver; Liver Diseases; Male; Myeloid Differentiation Factor 88; NF-kappa B; Pentacyclic Triterpenes; Rats, Sprague-Dawley; Signal Transduction; Toll-Like Receptor 4; Triterpenes; Tumor Necrosis Factor-alpha | 2016 |
Proteasome inhibitors, including curcumin, improve pancreatic β-cell function and insulin sensitivity in diabetic mice.
Topics: 3T3-L1 Cells; Animals; Body Composition; Cell Survival; Curcumin; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dietary Supplements; Glycated Hemoglobin; Homeostasis; Hyperglycemia; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Male; Mice; Mice, Inbred C57BL; Obesity; Oligopeptides; Pentacyclic Triterpenes; Polyphenols; Proteasome Inhibitors; Receptors, Leptin; Triterpenes | 2016 |
Withaferin A is a leptin sensitizer with strong antidiabetic properties in mice.
Topics: Animals; Blood Glucose; Blotting, Western; Body Weight; Diabetes Mellitus, Type 2; Diet, High-Fat; Fatty Liver; Fluorescent Antibody Technique; Glucose Tolerance Test; Hypothalamus; Immunohistochemistry; Leptin; Liver; Mice; Mice, Obese; Obesity; Pentacyclic Triterpenes; Real-Time Polymerase Chain Reaction; Signal Transduction; STAT3 Transcription Factor; Triterpenes; Withanolides | 2016 |